BioSpace News Archive

Invitation to Essity’s Q2 2018 Press Conference

The press conference held in connection with the publication of Essity’s interim report for the second quarter of 2018 will also be available via webcast and it is possible to join by phone.

June 20, 2018
·
1 min read
Business

TOT BIOPHARM’s 16,000L-capacitymonoclonal antibodies production base put into operation

Improving the quality of life for cancer patients worldwide with innovative science and technology

June 20, 2018
·
2 min read
Drug Development

GenSight Biologics : Key Opinion Leaders Highlight GS010 Efficacy and Patient Benefits in Discussion of Findings from REVERSE Phase III Clinical Trial

Preservation of anatomic structures combined with visual function improvement (contrast sensitivity) demonstrate neuro-protection in human genetic disease

June 20, 2018
·
11 min read
Business

TOT BIOPHARM’s 16,000L-capacity monoclonal antibodies production base put into operation

Improving the quality of life for cancer patients worldwide with innovative science and technology

June 20, 2018
·
2 min read
OASIS Maintains Safety Again at This Year’s Canadian Fair

OASIS International Hospital will once again take its place as this year’s Canadian Fair Medical Partner, providing medical assistance and peace of mind throughout the celebrations of Canada’s 151st Birthday.

June 20, 2018
·
1 min read
Business

BLDG Active is Changing the Meaning of ‘Over the Counter’

San Diego based start-up makes waves in the healthcare community

June 20, 2018
·
2 min read
Psoriasis Treatments to Become Cheaper as Biosimilars Compete in $5 Billion U.S. Psoriasis Drugs Market – New Study by iData Research

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis (PsO) every year in the United States, affecting 2.2% of the population.

June 20, 2018
·
2 min read
Policy

Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary®

Amneal Pharmaceuticals, Inc. announced that it has entered into a settlement agreement with Actavis Laboratories FL, Inc. and Actavis Pharma Inc. (collectively, “Actavis”) resolving patent litigation related to Rytary® (carbidopa-levodopa).

June 20, 2018
·
8 min read
Largest mental health bike ride in Canada aims to bring mental illness out of hiding

Ride Don’t Hide supports Canadians to open up and seek help

June 20, 2018
·
3 min read
BioMidwest

Blue Cross and Blue Shield Companies Improve Health in Communities Across the Country

Support continues for community initiatives to solve social determinants of health and combat the opioid epidemic

June 20, 2018
·
4 min read